Article

The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection

Department of Pediatrics, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA.
Sexually Transmitted Infections (Impact Factor: 3.08). 05/2006; 82(2):154-7; discussion 157-8. DOI: 10.1136/sti.2005.016311
Source: PubMed

ABSTRACT To evaluate the impact of a positive herpes simplex virus type 2 (HSV-2) serological test on psychosocial functioning among people with no known history of genital herpes.
Individuals (age 14-30 years) without a history of genital herpes were recruited from an urban university setting and sexually transmitted diseases (STD), primary care, and adolescent clinics. Participants completed a questionnaire addressing psychological functioning, psychosocial adjustment, and perceived quality of sex and were offered free HSV-2 antibody testing. 33 HSV-2 positive people and 60 HSV-2 negative people demographically matched from the same source of recruitment were re-evaluated at a 3 month follow up visit. HSV-2 positive participants also completed a genital herpes quality of life (GHQOL) measure.
Of the 33 who were HSV-2 seropositive, four did not recall their diagnosis. In comparing those who were HSV-2 positive with those who were negative, repeated measures analysis of variance indicated there were no significant differences over time on any of the measures. None the less, many HSV-2 positive individuals indicated that the diagnosis had a notable impact on their quality of life. Also, among the HSV-2 positive people, lower GHQOL at the 3 month follow up was predicted by higher interpersonal sensitivity (r = -0.44, p<0.05), lower social support (r = 0.40, p<0.05), and quality of sex (r = 0.62, p<0.01) at baseline.
A diagnosis of asymptomatic HSV-2 infection does not appear to cause significant lasting psychological difficulties. Those for whom the diagnosis had the greatest impact were interpersonally vulnerable before the diagnosis. These results suggest that assessment of interpersonal distress may be important to include as part of pretest and post-test counselling.

Download full-text

Full-text

Available from: Gregory Zimet, Sep 02, 2015
0 Followers
 · 
89 Views
 · 
68 Downloads
  • Source
    • "For example, HPV vaccination was launched with a price of around $360 per course in the US, but is now available through the Global Alliance for Vaccines and Immunization (GAVI) in low income countries for $4.50 [34]. The opportunity for tiered pricing is more apparent for the viral STIs, where a cure is not possible through current treatment, treatment of disease causes a burden on the system [32] and there is a psychosocial burden [35] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sexually transmitted diseases, a source of widespread morbidity and sometimes mortality, are caused by a diverse group of infections with a common route of transmission. Existing vaccines against hepatitis B virus (HBV) and human papilloma virus 16, 18, 6 and 11 are highly efficacious and cost effective. In reviewing the potential role for other vaccines against sexually transmitted infections (STIs) a series of questions needs to be addressed about the burden of disease, the potential characteristics of a new vaccine, and the impact of other interventions. These questions can be viewed in the light of the population dynamics of sexually transmitted infections as a group and how a vaccine can impact these dynamics. Mathematical models show the potential for substantial impact, especially if vaccines are widely used. To better make the case for sexually transmitted infection vaccines we need better data and analyses of the burden of disease, especially severe disease. However, cost effectiveness analyses using a wide range of assumptions show that STI vaccines would be cost effective and their development a worthwhile investment.
    Vaccine 03/2014; 32(14):1536–1542. DOI:10.1016/j.vaccine.2013.11.007 · 3.49 Impact Factor
  • Source
    • "HSV is a very stigmatizing disease, in part due to the incurable nature of the virus. The psychological distress and psychosexual problems associated with a diagnosis of HSV infection and recurrent HSV infections have been well described in the literature, though there is some debate as to whether these are due to long term effects of HSV infection or whether some patients are predisposed to anxiety [61-63], Carney demonstrated that suppressive therapy for HSV can result in reduction in anxiety [64]. As previously suggested, suppressive treatment in serodiscordant couples for HSV may not only increase the frequency of sex by reducing episodes of HSV, but also improve the psychological impact of HSV and concern regarding transmission, thereby improving sexual function. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Infertility affects about 8% to 12% of couples, with male infertility being responsible for about 30% of cases. Sexually transmitted infections (STIs) are known to cause complications of pregnancy and are associated with tubal infertility in females, but the association with male fertility is still controversial. The prevalence of curable STIs has risen to an estimated 448 million a year with the number of people living with human immunodeficiency virus (HIV) at 34 million. This review looks at the evidence available to date, regarding the effect of STIs and male accessory gland infections on markers of male fertility and the evidence that STIs negatively affect sexual functioning, thus adversely affecting the ability to conceive. The review will also cover new developments in the use of medications and fertility treatments as an aid to conception in couples serodiscordant for HIV.
    Korean journal of urology 03/2013; 54(3):149-56. DOI:10.4111/kju.2013.54.3.149
  • Source
    • "Interestingly, if one is asymptomatic but seropositive for herpes, the psychological effects remit about six months after the initial diagnosis (Rosenthal et al., 2006). With suppressive medication , an individual's quality of life also improves, due in part to the reduction of symptoms (Brentjens, Yeung-Yue, Lee, & Tyring, 2003). "
    [Show abstract] [Hide abstract]
    ABSTRACT: This article reviews the psychological consequences of genital herpes infection through the lens of a recently proposed framework for conceptualizing concealable stigmas. We incorporate research on identity, stigma, and the connection between psychological and physical health to outline how negative stigma-related psychological consequences perpetuate distress associated with genital herpes. Our review of the research suggests a model linking negative affect and poor coping to frequent recurrences of genital herpes outbreaks. Frequent outbreaks, in turn, increase the salience of the stigma, reinforcing a stigmatized self-schema, thereby creating negative psychological consequences, continuing the cycle. We conclude by discussing the implications of this model for future research and mental health treatment.
    Journal of Health Psychology 01/2011; 16(1):80-90. DOI:10.1177/1359105310367528 · 1.88 Impact Factor
Show more